TNF-antagonist etanercept induced reversible posterior leukoencephalopathy syndrome

Journal of Neurology

Volumn 255, Issue 3, 2008, Pages 452-453

  Kastrup, O ^a   Diener, H C ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; ETANERCEPT; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADULT; AGITATION; BABINSKI REFLEX; BRAIN DISEASE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC KIDNEY FAILURE; DISORIENTATION; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; FACE ASYMMETRY; HEADACHE; HUMAN; KIDNEY CLEARANCE; LABORATORY TEST; LETTER; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; POLYARTHRITIS; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; VISUAL HALLUCINATION;

ARTHRITIS, RHEUMATOID; BRAIN; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTORS;

EID: 41149132104     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-008-0732-y     Document Type: Letter

References (11)

1. Filley CM, Kleinschmidt-DeMasters BK (2001) Toxic leukoencephalopathy. N Engl J Med 345:425-432
2. Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN (2006) The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 33:2398-2408
3. Gijtenbeek JM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339-346
4. Kastrup O, Diener HC (1997) Granulocyte-stimulating factor filgrastim and molgramostim induced recurring encephalopathy and focal status epilepticus. J Neurol 244:274-275
5. Kastrup O, Maschke M, Wanke I, Diener HC (2002) Posterior reversible encephalopathy syndrome due to severe hypercalcemia. J Neurol 249:1563-1566
6. Ohtsuki S (2004) New aspects of the blood-brain barrier transporters; its physiological roles in the central nervous system. Biol Pharm Bull 27:1489-1496
7. Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, Antin JH (1995) Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MRT findings in 16 cases. AJR Am J Roentgenol 165:627-632
8. Shin IS, Baer AN, Kwon HJ, Papadopoulos EJ, Siegel JN (2006) Guillain-Barré and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum 54:1429-1434
9. Simsek I, Erdem H, Pay S, Sobaci G, Dinc A (2007) Optic neuritis occurring with anti-tumor necrosis factor-(alpha) therapy. Ann Rheum 24 (Epub ahead of print)
10. Wong D, Dorovini-Zis K, Vincent SR (2004) Cytokines, nitric oxide and cGMP modulate the permeability of an in vitro model of the human blood brain barrier. Exp Neurol 190:446-455
11. Yamamoto M, Takahashi H, Wakasugi H, Sugawa Y, Saito M, Suzuki C, Naishiro Y, Shinomura Y, Imai K (2007) Leukoencephalopathy during administration of etanercept for refractory rheumatoid arthritis. Mod Rheumatol 17:72-74